Top Markets
Coin of the day
Genenta Science S.p.A. Genenta Science S.p.A.

Genenta Science S.p.A.

GNTA
Kedudukan dalam Saham #28059
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
Harga Saham
$1.51
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$28.82M
Perubahan (1 hari)
-0.33%
Perubahan (1 tahun)
-57.49%
Negara
IT
Perdagangan Genenta Science S.p.A. (GNTA)

Kategori

Sejarah pecahan saham untuk Genenta Science S.p.A. (GNTA)
Saham Genenta Science S.p.A. (simbol: GNTA) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 20, 2026.
Satu saham GNTA yang dibeli sebelum Aug 20, 2026 kini bersamaan dengan 0 saham GNTA.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH